Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.

导出 LinkOut

翻译打印收藏纠错

作者： Mera,Alhusaini ^[1] ; Nermin,Eissa ^[2] ; Ali K,Saad ^[1] ; Rami,Beiram ^[2] ; Bassem,Sadek ^[3]

作者单位： Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. ^[1] Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. ^[2] Department of Biomedical Sciences, College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates. ^[3]

关键词 H3R H3R inverse agonists antagonists histaminergic system neurological disorders neurotransmitters

DOI 10.3389/fphar.2022.861094

PMID 35721194

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

861094页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除